Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Advanced Course on EGFR Exon 20 Insertion Mutations in NSCLC: Optimising Patient Diagnosis and Management

05 - 06 Dec 2022

Singapore, Republic of Singapore


Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives
  • To understand the function and biology of EGFR and exon 20 insertion mutations in normal and malignant lung epithelial cells
  • To gain insights in the spectrum of atypical EGFR molecular aberrations, platforms and strategies for molecular testing
  • To provide information and in-depth discussion on the state-of-the-art and emerging therapeutic strategies integrating EGFR exon 20 insertion mutation inhibition in non-small-cell lung cancer
  • To present novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of EGFR exon 20 mutation inhibition

This event has been supported by an unrestricted educational grant from Janssen.

Filter by:

There are 16 resources available

Welcome and Introduction

Presenter: S. Popat, UK and R. A. Soo, SG

Session: Welcome and Introduction




This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.